Use of metals to treat inflammatory skin conditions

Details for Australian Patent Application No. 2002252881 (hide)

Owner Nucryst Pharmaceuticals Corp.

Inventors Yin, Hua Qing; Burrell, Robert Edward

Agent Davies Collison Cave

Pub. Number AU-B-2002252881

PCT Pub. Number WO2002/085387

Priority 09/840,637 23.04.01 US; 60/285,884 23.04.01 US

Filing date 23 April 2002

Wipo publication date 5 November 2002

Acceptance publication date 26 July 2007

International Classifications

A61K 9/02 (2006.01) Medicinal preparations characterised by special physical form - Suppositories

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 9/68 (2006.01) Medicinal preparations characterised by special physical form - chewing gum type

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 33/38 (2006.01) Medicinal preparations containing inorganic active ingredients - Silver

A61L 15/44 (2006.01) Chemical aspects of bandages, dressings, or absorbent pads or use of materials for their realisation

A61L 15/46 (2006.01) Chemical aspects of bandages, dressings, or absorbent pads or use of materials for their realisation

A61L 17/14 (2006.01) Materials for surgical sutures or for ligaturing blood vessels

A61L 27/30 (2006.01) Materials for prostheses or for coating prostheses

A61L 29/10 (2006.01) Materials for catheters or for coating catheters

A61L 31/08 (2006.01) Materials for other surgical articles - Materials for coatings

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 Drugs for disorders of the respiratory system

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002252881

26 July 2007 Application Accepted

  Published as AU-B-2002252881

22 November 2007 Standard Patent Sealed

15 July 2010 Assignment Registered

  Nucryst Pharmaceuticals Corp. The patent has been assigned to Smith & Nephew (Overseas) Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002252882-ACCOUNTING IN PEER-TO-PEER DATA COMMUNICATION NETWORKS

2002252880-sETHOD OF INDUCTION OF APOPTOSIS AND INHIBITION OF MATRIX METALLOPROTEINASES USING ANTIMICROBIAL METALS